Blonanserin is a second-generation atypical antipsychotic agent used for the treatment of schizophrenia, functioning as a potent antagonist at both serotonin 5-HT2A and dopamine D2 receptors. To ensure… Read more
![Chemical structure of 2-(4-Ethylpiperazin-1-yl)-4-(4-(4-ethylpiperazin-1-yl)phenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1648791-23-4-2-4-Ethylpiperazin-1-yl-4-4-4-ethylpiperazin-1-ylphenyl-5678910-hexahydrocyclooctabpyridine.png&w=3840&q=75)
![Chemical structure of 2-(4-Ethylpiperazin-1-yl)-4-(4-methoxyphenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F132810-93-6-2-4-Ethylpiperazin-1-yl-4-4-methoxyphenyl-5678910-hexahydrocyclooctabpyridine.png&w=3840&q=75)
![Chemical structure of 2-(4-Ethylpiperazin-1-yl)-4-phenyl-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F132810-75-4-2-4-Ethylpiperazin-1-yl-4-phenyl-5678910-hexahydrocyclooctabpyridine.png&w=3840&q=75)
![Chemical structure of 2-Chloro-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F132813-14-0-2-Chloro-4-4-fluorophenyl-5678910-hexahydrocyclooctabpyridine.png&w=3840&q=75)
![Chemical structure of 4-(4-Chlorophenyl)-2-(4-ethylpiperazin-1-yl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F132810-87-8-4-4-Chlorophenyl-2-4-ethylpiperazin-1-yl-5678910-hexahydrocyclooctabpyridine.png&w=3840&q=75)
![Chemical structure of 4-(4-Fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridin-2(1H)-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F132812-72-7-4-4-Fluorophenyl-5678910-hexahydrocyclooctabpyridin-21H-one.png&w=3840&q=75)


































Blonanserin is a second-generation atypical antipsychotic agent used for the treatment of schizophrenia, functioning as a potent antagonist at both serotonin 5-HT2A and dopamine D2 receptors. To ensure the safety and efficacy of this pharmaceutical, analytical laboratories rely on a precise range of reference standards to support rigorous quality control and method validation protocols. This category encompasses the API, along with its related substances, including complex process-related impurities and degradation products, which are vital for accurate impurity profiling during drug development and stability testing. Furthermore, stable isotope labelled compounds are available to serve as reliable internal standards for mass spectrometry-based bioanalytical assays, facilitating the quantification of the drug and its metabolites in complex matrices. These tools are essential for maintaining compliance with regulatory standards and ensuring high-quality analytical outcomes throughout the pharmaceutical lifecycle.